Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. (2020)
Attributed to:
Cannabidiol: a novel treatment for cannabis dependence?
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(20)30290-x
PubMed Identifier: 32735782
Publication URI: http://europepmc.org/abstract/MED/32735782
Type: Journal Article/Review
Volume: 7
Parent Publication: The lancet. Psychiatry
Issue: 10
ISSN: 2215-0366